Molly C. Mack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Molly C. Mack has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Erika Friehling
Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
2 shared publicationsErika Moore
Department of Pathology University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
2 shared publicationsLaila Khatib
Department of Pediatrics UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA
2 shared publicationsMeghan McCormick
Department of Pediatric Hematology/Oncology University of Miami Miami Florida USA
2 shared publications- Scott H. Maurer
Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
2 shared publications Brittani K. N. Seynnaeve
Department of Pediatrics University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
1 shared publication
Latest Publications
- Open Access
- 24 September 2026
- Published by Wiley in Pediatric Blood & Cancer
Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers
Background: Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks. Methods: We conducted a cross‐sectional, mixed‐methods study of children and adolescents and young adults (AYA) receiving active cancer treatment and peers without chronic medical conditions. Participants completed surveys assessing loneliness using the Revised UCLA Loneliness Scale (RULS‐8), emotional distress, and social connection strategies. Qualitative thematic analysis was performed on open‐ended responses to identify subject‐reported contributors to loneliness and mitigation strategies. Results: Sixty‐six participants were enrolled, equally divided between oncologic and non‐oncologic groups. Overall, 15% met criteria for loneliness, 70% of whom were receiving cancer therapy. Although loneliness prevalence did not differ by cancer status, oncology patients self‐reported significantly higher depressive symptoms ( p = 0.0281) and greater perceived burden of loneliness ( p = 0.0432). Social interaction was widely identified as protective against loneliness, and oncology patients more frequently identified social media as a strategy to reduce loneliness relative to non‐oncologic patients (58% vs. 20%). Qualitative analysis identified physical isolation, emotional isolation, and social exclusion as primary contributors to loneliness, with “medical exclusion” as a unique theme among oncology patients. Conclusions: While cancer diagnosis alone did not predict loneliness, pediatric oncology patients experienced greater depressive symptoms and adverse effects associated with loneliness. Screening for loneliness and supporting adaptive social connection strategies may represent important opportunities for pediatric hematology/oncology and primary care providers to improve psychosocial care during and after cancer therapy.
- 24 September 2026
- Published by Wiley in Pediatric Blood & Cancer
Open AccessBridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers
Background: Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks. Methods: We conducted a cross‐sectional, mixed‐methods study of children and adolescents and young adults (AYA) receiving active cancer treatment and peers without chronic medical conditions. Participants completed surveys assessing loneliness using the Revised UCLA Loneliness Scale (RULS‐8), emotional distress, and social connection strategies. Qualitative thematic analysis was performed on open‐ended responses to identify subject‐reported contributors to loneliness and mitigation strategies. Results: Sixty‐six participants were enrolled, equally divided between oncologic and non‐oncologic groups. Overall, 15% met criteria for loneliness, 70% of whom were receiving cancer therapy. Although loneliness prevalence did not differ by cancer status, oncology patients self‐reported significantly higher depressive symptoms ( p = 0.0281) and greater perceived burden of loneliness ( p = 0.0432). Social interaction was widely identified as protective against loneliness, and oncology patients more frequently identified social media as a strategy to reduce loneliness relative to non‐oncologic patients (58% vs. 20%). Qualitative analysis identified physical isolation, emotional isolation, and social exclusion as primary contributors to loneliness, with “medical exclusion” as a unique theme among oncology patients. Conclusions: While cancer diagnosis alone did not predict loneliness, pediatric oncology patients experienced greater depressive symptoms and adverse effects associated with loneliness. Screening for loneliness and supporting adaptive social connection strategies may represent important opportunities for pediatric hematology/oncology and primary care providers to improve psychosocial care during and after cancer therapy.
- 29 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70428
Circulating Tumor DNA as a Potential Biomarker for Extracranial Disease Monitoring in Pediatric Melanoma: A Case Report
- 29 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70428
Circulating Tumor DNA as a Potential Biomarker for Extracranial Disease Monitoring in Pediatric Melanoma: A Case Report
- 30 December 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (2) , e70088
Concurrent Mixed Phenotypic Acute Leukemia and T‐Lymphoblastic Lymphoma in an Adolescent Male
- 30 December 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (2) , e70088
Concurrent Mixed Phenotypic Acute Leukemia and T‐Lymphoblastic Lymphoma in an Adolescent Male
- Open Access
- 15 October 2025
- Published by Wiley
Concurrent Mixed Phenotypic Acute Leukemia and T-Lymphoblastic Lymphoma in an Adolescent Male
- 15 October 2025
- Published by Wiley
Open AccessConcurrent Mixed Phenotypic Acute Leukemia and T-Lymphoblastic Lymphoma in an Adolescent Male
- Open Access
- 21 July 2025
- Published by Wiley in Pediatric Blood & Cancer
- p. e31912
Peds OncoTalk: A Curriculum to Teach Communication Skills to Pediatric Hematology/Oncology Fellows
Background: Peds OncoTalk is a novel curriculum for Pediatric Hematology/Oncology (PHO) fellows to learn key communication skills to deliver cancer care using validated principles. Interpersonal and communication skills are core competencies for Accreditation Council for Graduate Medical Education (ACGME)‐accredited PHO fellowship.Methods: A 3‐day, virtual course emphasizing skill practice in small groups with simulated patients was created. Participants completed pre‐ and postsurveys to measure reported preparedness with skills on a 5‐point Likert scale. The course teaches responding to emotion, delivering serious news, mapping values, and proposing a values‐based plan. Didactic sessions were followed by simulated patient cases facilitated by Vital Talk Faculty. PHO‐specific content: 1. New diagnosis of acute lymphoblastic leukemia; 2. Adolescent patient with relapsed osteosarcoma; 3. End‐of‐life care for child with progressive diffuse intrinsic pontine glioma.Results: Eighteen fellows from six ACGME‐accredited institutions participated. Learners reported improved confidence in all measured skills: deliver serious news (pre 3.33, post 4.44, mean difference 1.11, p < 0.01); explore values to develop a treatment plan (pre 2.78, post 4.39, p < 0.01); and propose a values‐concordant plan (pre 2.94, post 4.28, p < 0.01). Sixteen of 18 (89%) fellows stated agree to strongly agree when asked if the course should be required training. All fellows (100%) responded that content was relevant to training.Conclusions: Formal, simulated communication training improves confidence in fundamental communication skills for PHO fellows. Fellows reported this training should be required. The virtual platform provides improved accessibility. These skills are critical to providing values‐based care to a vulnerable population, and the course should be integrated into PHO training.
- 21 July 2025
- Published by Wiley in Pediatric Blood & Cancer
- p. e31912
Open AccessPeds OncoTalk: A Curriculum to Teach Communication Skills to Pediatric Hematology/Oncology Fellows
Background: Peds OncoTalk is a novel curriculum for Pediatric Hematology/Oncology (PHO) fellows to learn key communication skills to deliver cancer care using validated principles. Interpersonal and communication skills are core competencies for Accreditation Council for Graduate Medical Education (ACGME)‐accredited PHO fellowship.Methods: A 3‐day, virtual course emphasizing skill practice in small groups with simulated patients was created. Participants completed pre‐ and postsurveys to measure reported preparedness with skills on a 5‐point Likert scale. The course teaches responding to emotion, delivering serious news, mapping values, and proposing a values‐based plan. Didactic sessions were followed by simulated patient cases facilitated by Vital Talk Faculty. PHO‐specific content: 1. New diagnosis of acute lymphoblastic leukemia; 2. Adolescent patient with relapsed osteosarcoma; 3. End‐of‐life care for child with progressive diffuse intrinsic pontine glioma.Results: Eighteen fellows from six ACGME‐accredited institutions participated. Learners reported improved confidence in all measured skills: deliver serious news (pre 3.33, post 4.44, mean difference 1.11, p < 0.01); explore values to develop a treatment plan (pre 2.78, post 4.39, p < 0.01); and propose a values‐concordant plan (pre 2.94, post 4.28, p < 0.01). Sixteen of 18 (89%) fellows stated agree to strongly agree when asked if the course should be required training. All fellows (100%) responded that content was relevant to training.Conclusions: Formal, simulated communication training improves confidence in fundamental communication skills for PHO fellows. Fellows reported this training should be required. The virtual platform provides improved accessibility. These skills are critical to providing values‐based care to a vulnerable population, and the course should be integrated into PHO training.
- Open Access
- 25 May 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (8) , e31816
Patterns of Direct Oral Anticoagulant Use in Pediatric Patients: Results From a Multicenter National Database
Background: Direct oral anticoagulants (DOACs) have quickly gained favor due to oral availability, favorable risk profile, and reduced lab monitoring. This study aims to evaluate trends in DOAC use among pediatric patients with new venous thrombotic events (VTE) and factors associated with their selection.Procedure: This was a retrospective study using the Pediatric Health Information System (PHIS) administrative database. We included initial inpatient encounters from 2014 to 2021 for children (age 0–18 years) with an ICD‐9 or ICD‐10 code for VTE. We compared characteristics of patients who received DOACs to those who did not, through descriptive and statistical analysis and evaluated factors associated with DOAC selection with logistic regression.Results: In 20,332 cases of new VTE, DOACs were administered in 810 encounters (3.98%), most commonly rivaroxaban (75.1% of cases). DOAC use increased over time to 12.0% of encounters in 2021. Patients who received DOACs had greater median age (16 vs. 4 years, p < 0.001), were more commonly female (51.6% vs. 46.7%, p = 0.007), had greater median income ($64,908 vs. $57,165, p < 0.001), and were more likely to carry private insurance (47% vs. 41%, p = 0.003). Patients who received DOACs had lower average hospitalization duration, hospitalization costs, and were less likely to have a complex chronic condition. On regression analysis, factors associated with DOAC use included older age, increased income, and geographic region (p < 0.05).Conclusions: DOACs are increasingly used in pediatric patients. Decision‐making appears to be affected by patient age, medical comorbidities, and income, suggesting prescription trends may not be based on clinical evidence alone.
- 25 May 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (8) , e31816
Open AccessPatterns of Direct Oral Anticoagulant Use in Pediatric Patients: Results From a Multicenter National Database
Background: Direct oral anticoagulants (DOACs) have quickly gained favor due to oral availability, favorable risk profile, and reduced lab monitoring. This study aims to evaluate trends in DOAC use among pediatric patients with new venous thrombotic events (VTE) and factors associated with their selection.Procedure: This was a retrospective study using the Pediatric Health Information System (PHIS) administrative database. We included initial inpatient encounters from 2014 to 2021 for children (age 0–18 years) with an ICD‐9 or ICD‐10 code for VTE. We compared characteristics of patients who received DOACs to those who did not, through descriptive and statistical analysis and evaluated factors associated with DOAC selection with logistic regression.Results: In 20,332 cases of new VTE, DOACs were administered in 810 encounters (3.98%), most commonly rivaroxaban (75.1% of cases). DOAC use increased over time to 12.0% of encounters in 2021. Patients who received DOACs had greater median age (16 vs. 4 years, p < 0.001), were more commonly female (51.6% vs. 46.7%, p = 0.007), had greater median income ($64,908 vs. $57,165, p < 0.001), and were more likely to carry private insurance (47% vs. 41%, p = 0.003). Patients who received DOACs had lower average hospitalization duration, hospitalization costs, and were less likely to have a complex chronic condition. On regression analysis, factors associated with DOAC use included older age, increased income, and geographic region (p < 0.05).Conclusions: DOACs are increasingly used in pediatric patients. Decision‐making appears to be affected by patient age, medical comorbidities, and income, suggesting prescription trends may not be based on clinical evidence alone.
- Open Access
- 17 June 2021
- Published by Wiley
Hospitalization For Iron Deficiency Anemia In Young Children: A Multicenter Analysis
Background Iron deficiency anemia (IDA) is detrimental to growth and neurodevelopmental outcomes in young children. IDA is primarily managed in the outpatient setting, though children with severe anemia may require admission. No prior studies of children with severe IDA admitted to US children’s hospitals exist. The objective is to describe characteristics of children requiring admission for IDA. Procedure Using the Pediatric Health Information system database, we identified children age 0-5 years admitted from 2004-2018 with a primary diagnosis of IDA. Patient characteristics were compared by chi-square test or t-test of means. Univariate logistic regression was used to identify factors associated with readmission. We also performed a retrospective review of primary care records. Results A total of 4963 unique patients were identified, with 5202 unique hospitalizations. The mean age at admission at index hospitalization was 1.5 years with no gender difference. A trend towards an increasing number of admissions was noted in recent years. The majority of the patients received blood transfusions (87.3%) and oral iron (61.4%), whereas only 4.9% of patients received intravenous iron. Overall, 13.1% of patients required ICU admission, which was more common in female patients and children of Black or Asian race. Factors associated with decreased odds of readmission included blood product transfusion and use of oral iron during the index hospitalization. Conclusions IDA is a preventable condition, with potential for detrimental long-term outcomes. Trends in the number of admissions over time are concerning in light of the substantial use of hospital resources.
- 17 June 2021
- Published by Wiley
Open AccessHospitalization For Iron Deficiency Anemia In Young Children: A Multicenter Analysis
Background Iron deficiency anemia (IDA) is detrimental to growth and neurodevelopmental outcomes in young children. IDA is primarily managed in the outpatient setting, though children with severe anemia may require admission. No prior studies of children with severe IDA admitted to US children’s hospitals exist. The objective is to describe characteristics of children requiring admission for IDA. Procedure Using the Pediatric Health Information system database, we identified children age 0-5 years admitted from 2004-2018 with a primary diagnosis of IDA. Patient characteristics were compared by chi-square test or t-test of means. Univariate logistic regression was used to identify factors associated with readmission. We also performed a retrospective review of primary care records. Results A total of 4963 unique patients were identified, with 5202 unique hospitalizations. The mean age at admission at index hospitalization was 1.5 years with no gender difference. A trend towards an increasing number of admissions was noted in recent years. The majority of the patients received blood transfusions (87.3%) and oral iron (61.4%), whereas only 4.9% of patients received intravenous iron. Overall, 13.1% of patients required ICU admission, which was more common in female patients and children of Black or Asian race. Factors associated with decreased odds of readmission included blood product transfusion and use of oral iron during the index hospitalization. Conclusions IDA is a preventable condition, with potential for detrimental long-term outcomes. Trends in the number of admissions over time are concerning in light of the substantial use of hospital resources.